-
2
-
-
0036886338
-
Patients with psoriasis prefer solution and foam vehicles: A quantitative assessment of vehicle preference
-
Housman TS et al. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 2002 70: 327 332.
-
(2002)
Cutis
, vol.70
, pp. 327-332
-
-
Housman, T.S.1
-
3
-
-
33751225645
-
Emollient foam in topical drug delivery
-
Tamarkin D et al. Emollient foam in topical drug delivery. Expert Opin Drug Deliv 2006 3: 799 807.
-
(2006)
Expert Opin Drug Deliv
, vol.3
, pp. 799-807
-
-
Tamarkin, D.1
-
4
-
-
77953583915
-
The vehicle found in ketoconazole foam 2% is preferred by patients with mild to severe seborrheic dermatitis over other vehicles, regardless of gender, age, or ethnicity
-
Cash K, Quigley MO. The vehicle found in ketoconazole foam 2% is preferred by patients with mild to severe seborrheic dermatitis over other vehicles, regardless of gender, age, or ethnicity. J Am Acad Dermatol 2008 58: AB92.
-
(2008)
J Am Acad Dermatol
, vol.58
, pp. 92
-
-
Cash, K.1
Quigley, M.O.2
-
5
-
-
0038163576
-
The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions
-
Gottlieb AB et al. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. J Cutan Med Surg 2003 7: 185 192.
-
(2003)
J Cutan Med Surg
, vol.7
, pp. 185-192
-
-
Gottlieb, A.B.1
-
6
-
-
48249156924
-
Desonide: A review of formulations, efficacy and safety
-
Kahanek N et al. Desonide: a review of formulations, efficacy and safety. Expert Opin Investig Drugs 2008 17: 1097 1104.
-
(2008)
Expert Opin Investig Drugs
, vol.17
, pp. 1097-1104
-
-
Kahanek, N.1
-
7
-
-
47049092199
-
Desonide foam 0.05%: Safety in children as young as 3 months
-
Hebert AA. Desonide foam 0.05%: safety in children as young as 3 months. J Am Acad Dermatol 2008 59: 334 340.
-
(2008)
J Am Acad Dermatol
, vol.59
, pp. 334-340
-
-
Hebert, A.A.1
-
8
-
-
48749099907
-
Clobetasol propionate emulsion formulation foam 0.05%: Review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents
-
Kimball AB et al. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 2008 59: 448 454.
-
(2008)
J Am Acad Dermatol
, vol.59
, pp. 448-454
-
-
Kimball, A.B.1
-
9
-
-
0034853330
-
Betamethasone valerate foam for treatment of nonscalp psoriasis
-
Stein LF et al. Betamethasone valerate foam for treatment of nonscalp psoriasis. J Cutan Med Surg 2001 5: 303 307.
-
(2001)
J Cutan Med Surg
, vol.5
, pp. 303-307
-
-
Stein, L.F.1
-
10
-
-
17544362634
-
The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris
-
Shalita AR et al. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. J Drugs Dermatol 2005 4: 48 56.
-
(2005)
J Drugs Dermatol
, vol.4
, pp. 48-56
-
-
Shalita, A.R.1
-
11
-
-
49649096627
-
Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses
-
Frangos JE, Kimball AB. Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses. Expert Opin Pharmacother 2008 9: 2001 2007.
-
(2008)
Expert Opin Pharmacother
, vol.9
, pp. 2001-2007
-
-
Frangos, J.E.1
Kimball, A.B.2
-
12
-
-
0036062441
-
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis
-
Lebwohl M et al. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol 2002 41: 269 274.
-
(2002)
Int J Dermatol
, vol.41
, pp. 269-274
-
-
Lebwohl, M.1
-
13
-
-
20444461545
-
A novel foam vehicle for delivery of topical corticosteroids
-
Huang X et al. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol 2005 53: S26 S38.
-
(2005)
J Am Acad Dermatol
, vol.53
-
-
Huang, X.1
-
14
-
-
20444456597
-
Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis
-
Stein L. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis. J Am Acad Dermatol 2005 53: S39 S49.
-
(2005)
J Am Acad Dermatol
, vol.53
-
-
Stein, L.1
-
15
-
-
34248999760
-
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis
-
Mazzotta A et al. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. J Dermatol Treat 2007 18: 84 87.
-
(2007)
J Dermatol Treat
, vol.18
, pp. 84-87
-
-
Mazzotta, A.1
-
16
-
-
0032807315
-
Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy
-
Franz TJ et al. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999 38: 628 632.
-
(1999)
Int J Dermatol
, vol.38
, pp. 628-632
-
-
Franz, T.J.1
-
17
-
-
0037238007
-
Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: An open, multicentre, randomized, controlled, cross-over study on 241 patients
-
Andreassi L et al. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol 2003 148: 134 138.
-
(2003)
Br J Dermatol
, vol.148
, pp. 134-138
-
-
Andreassi, L.1
-
18
-
-
0038607714
-
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator-blinded trial
-
Mancuso G et al. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol 2003 42: 572 575.
-
(2003)
Int J Dermatol
, vol.42
, pp. 572-575
-
-
Mancuso, G.1
-
19
-
-
0038005103
-
Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: An open-label, multicentre, prospective trial on 180 patients
-
Milani M et al. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients. Curr Med Res Opin 2003 19: 342 345.
-
(2003)
Curr Med Res Opin
, vol.19
, pp. 342-345
-
-
Milani, M.1
-
20
-
-
35148886772
-
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
-
Olsen EA et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007 57: 767 774.
-
(2007)
J Am Acad Dermatol
, vol.57
, pp. 767-774
-
-
Olsen, E.A.1
-
21
-
-
84925559684
-
The treatment of hyperkeratosis with a new, 30% urea emollient foam: A series of case studies
-
Goldstein J, Gurge R. The treatment of hyperkeratosis with a new, 30% urea emollient foam: a series of case studies. J Am Acad Dermatol 2008 58: AB41.
-
(2008)
J Am Acad Dermatol
, vol.58
, pp. 41
-
-
Goldstein, J.1
Gurge, R.2
-
22
-
-
84925566661
-
-
Weaire, D. Hutzler, S. eds
-
Weaire D, Hutzler S, eds. The Physics of Foams.
-
The Physics of Foams.
-
-
-
23
-
-
20444482549
-
Foam drug delivery in dermatology: Beyond the scalp
-
Purdon CH et al. Foam drug delivery in dermatology: beyond the scalp. Am J Drug Deliv 2003 1: 71 75.
-
(2003)
Am J Drug Deliv
, vol.1
, pp. 71-75
-
-
Purdon, C.H.1
-
25
-
-
77953587701
-
-
Anon. In: Handbook for the Montreal Protocol on Substances That Deplete the Ozone Layer. 7th edn
-
Anon. Summary of control measures under the Montreal Protocol. In: Handbook for the Montreal Protocol on Substances That Deplete the Ozone Layer, 7th edn. 2006: 27 40.
-
(2006)
Summary of Control Measures under the Montreal Protocol
, pp. 27-40
-
-
-
26
-
-
0032790248
-
Drug-surfactant-propellant interactions in HFA-formulations
-
Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm 1999 186: 13 30.
-
(1999)
Int J Pharm
, vol.186
, pp. 13-30
-
-
Vervaet, C.1
Byron, P.R.2
-
27
-
-
0034658554
-
Transition to CFC-free metered dose inhalers-into the new millennium
-
McDonald KJ, Martin GP. Transition to CFC-free metered dose inhalers-into the new millennium. Int J Pharm 2000 201: 89 107.
-
(2000)
Int J Pharm
, vol.201
, pp. 89-107
-
-
McDonald, K.J.1
Martin, G.P.2
-
28
-
-
84925569324
-
Polymers for the colloidal stabilization of drugs in HFAs
-
Wright P. Polymers for the colloidal stabilization of drugs in HFAs. RDD IV 2006 1: 243 248.
-
(2006)
RDD IV
, vol.1
, pp. 243-248
-
-
Wright, P.1
-
29
-
-
17644366769
-
Surfactant solubility and aggregate orientation in hydrofluoroalkanes
-
Ridder KB et al. Surfactant solubility and aggregate orientation in hydrofluoroalkanes. Int J Pharm 2005 295: 57 65.
-
(2005)
Int J Pharm
, vol.295
, pp. 57-65
-
-
Ridder, K.B.1
-
36
-
-
0021980791
-
Foams in pharmacy
-
Pilpel N. Foams in pharmacy. Endeavour 1985 9: 87 91.
-
(1985)
Endeavour
, vol.9
, pp. 87-91
-
-
Pilpel, N.1
-
39
-
-
67349130576
-
Engineering novel topical foams using hydrofluroalkane emulsions stabilised with pluronic surfactants
-
Zhao Y et al. Engineering novel topical foams using hydrofluroalkane emulsions stabilised with pluronic surfactants. Eur J Pharm Sci 2009 37: 370 377.
-
(2009)
Eur J Pharm Sci
, vol.37
, pp. 370-377
-
-
Zhao, Y.1
-
40
-
-
14844329941
-
Experimental techniques for the characterization of foams
-
1st edn. Prud'homme, R.K. Khan, S.A. eds
-
Wilson AJ. Experimental techniques for the characterization of foams. In Prud'homme RK, Khan SA, eds. Foams: Theory, Measurement and Applications, 1st edn.
-
Foams: Theory, Measurement and Applications
-
-
Wilson, A.J.1
-
41
-
-
0037439637
-
Perspectives on foam drainage and the influence of interfacial rheology
-
Stone HA et al. Perspectives on foam drainage and the influence of interfacial rheology. J Phys Condens Matter 2003 15: S283 S290.
-
(2003)
J Phys Condens Matter
, vol.15
-
-
Stone, H.A.1
-
42
-
-
41149124408
-
Aqueous foams: A field of investigation at the frontier between chemistry and physics
-
Langevin D. Aqueous foams: A field of investigation at the frontier between chemistry and physics. Chemphyschem 2008 9: 510 522.
-
(2008)
Chemphyschem
, vol.9
, pp. 510-522
-
-
Langevin, D.1
-
44
-
-
84925566661
-
-
Weaire, D. Hutzler, S. eds
-
Weaire D, Hutzler S eds. The Physics of Foams.
-
The Physics of Foams.
-
-
-
45
-
-
41549148681
-
The rheological properties of pharmaceutical foam: Implications for use
-
Kealy T et al. The rheological properties of pharmaceutical foam: implications for use. Int J Pharm 2008 355: 67 80.
-
(2008)
Int J Pharm
, vol.355
, pp. 67-80
-
-
Kealy, T.1
-
46
-
-
33750345304
-
Microscopic and thermodynamic properties of the HFA134a-water interface: Atomistic computer simulations and tensiometry under pressure
-
Peguin RPS et al. Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure. Langmuir 2006 22: 8826 8830.
-
(2006)
Langmuir
, vol.22
, pp. 8826-8830
-
-
Peguin, R.P.S.1
-
47
-
-
33750285649
-
Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: Ab initio calculations and in situ high-pressure tensiometry
-
Selvam P et al. Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: ab initio calculations and in situ high-pressure tensiometry. Langmuir 2006 22: 8675 8683.
-
(2006)
Langmuir
, vol.22
, pp. 8675-8683
-
-
Selvam, P.1
-
48
-
-
60849136012
-
Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles
-
Chokshi U et al. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles. Int J Pharm 2009 369: 176 184.
-
(2009)
Int J Pharm
, vol.369
, pp. 176-184
-
-
Chokshi, U.1
-
49
-
-
0034039616
-
Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
-
Feldman SR et al. Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles. J Am Acad Dermatol 2000 42: 1017 1020.
-
(2000)
J Am Acad Dermatol
, vol.42
, pp. 1017-1020
-
-
Feldman, S.R.1
-
50
-
-
20444461545
-
A novel foam vehicle for delivery of topical corticosteroids
-
Huang X et al. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol 2005 53: S26 S38.
-
(2005)
J Am Acad Dermatol
, vol.53
-
-
Huang, X.1
-
56
-
-
67449155891
-
A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ
-
Zhao Y et al. A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ. Eur J Pharm Biopharm 2009 72: 521 528.
-
(2009)
Eur J Pharm Biopharm
, vol.72
, pp. 521-528
-
-
Zhao, Y.1
|